Novartis Gene Therapies
2275 Half Day Road, Suite 200
Bannockburn
Illinois
60015
United States
Tel: 847.572.8280
Website: https://www.novartis.com/
About Novartis Gene Therapies
Since 2013, Novartis Gene Therapies (formerly AveXis) has had one focus: bringing change to those devastated by genetic diseases.
The Novartis Gene Therapies culture embraces this mission. As a compassionate and dedicated team, we are enthusiastic about the science behind our work and finding answers to difficult questions. We are dedicated to communities affected by rare diseases, and these patients and families are the motivation for everything we do.
We have built a team with exceptional depth of experience, unified by a common vision; to develop gene therapies with the potential to positively impact the lives of the patients and families devastated by rare and life-threatening neurological genetic diseases. Though we are proud of what we have achieved to date, we remain relentlessly focused on making that vision a reality.
With cutting-edge technology, we are making progress in the treatment of rare and life-threatening neurological genetic diseases. Our initial gene therapy for spinal muscular atrophy (SMA) has been approved in the U.S., Japan, EU and Brazil.
We are headquartered in Bannockburn, IL with another location in Deerfield, IL. Our manufacturing facilities are located in Libertyville, IL, Durham, NC and Longmont, CO. Our research site is located in San Diego, CA. The European headquarters is located in Zurich, Switzerland and Novartis Pharma K.K. (“Novartis Pharma”) is located in Tokyo, Japan.
Ownership: Public
Stock Symbol: NVS
Stock Exchange: NYSE
92 jobs with Novartis Gene Therapies
-
Maintenance and Reliability Technician - Lead
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Associate Director, Technical Research & Development - Labs (Analytical)
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Maintenance Planner
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Supply Chain Intern (Purchasing)
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Internship, Manufacturing Associate/BioProcess - Libertyville, Illinois
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
-
Process Engineering Intern
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Senior Specialist, Data Integrity Quality Operations
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Principal Biostatistician
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Director, Technical Program Lead
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
BioProcess Technician I - Downstream
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
US Medical Director, External Engagement
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Intern, In vivo
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Gene Therapy Intern - Molecular Biology
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Gene Therapy Intern - In vitro Cell Potency Assay
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Research Associate II, Molecular Biology
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Internship, Corporate Communications
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Intern, Analytical Chemistry
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Internship, Site Quality Operations
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Automation Intern
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge
-
Research Associate II, Analytical Development - Chem Test
Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological ge